Paradigm Biocapital Advisors LP

2 filings 2 distinct issuers Active 2026-06-24 → 2026-06-26

Track Record

Total filings

2 SCHEDULE 13G

Distinct issuers

100% issuer diversity

Median stake

—

AI briefs cached

0/2

intent-classified filings

Filed	Form	Issuer	Stake	Shares	Intent
2026-06-26	SCHEDULE 13G	Viridian Therapeutics, Inc.VRDN	—	—		view →
2026-06-24	SCHEDULE 13G	MBX Biosciences, Inc.MBX	—	—		view →

Free. We email you when criteria match. One-click unsubscribe in every email.

Custom alerts on filer activity · full feed access · daily intelligence · API. $1,500/mo. Pilots welcome.